Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate

By Perrotti M.   Bahamondes L.   Petta C.   Castro S.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 469-473

Elsevier

Access to resources Recommend Favorite

The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women

By Scholes D.   LaCroix A.Z.   Ichikawa L.E.   Barlow W.E.   Ott S.M.  

Contraception, Vol. 69, Iss. 2, 2004-02 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Effect of depot medroxyprogesterone acetate on bone density in a Scottish industrial city

By McGough Pauline   Bigrigg Alison  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 253-259

Informa Healthcare

Access to resources Recommend Favorite

Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum

By Sönmezer M   Atabekoğlu C   Cengiz B   Dökmeci F   Cengiz SD  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 1, 2005-03 ,pp. : 9-14

Informa Healthcare

Access to resources Recommend Favorite

The effects of a 3-month depot preparation of leuprorelin acetate on pain symptoms, bone mineral density and hormone levels in women with endometriosis—preliminary data analysis

By Baxter Niki   Duffy Sean  

Gynecological Surgery, Vol. 1, Iss. 2, 2004-06 ,pp. : 107-109

Springer Publishing Company

Access to resources Recommend Favorite